Efficacy and Safety of a Fixed-Dose Combination Gel with Adapalene 0.1% and Clindamycin 1% for the Treatment of Acne Vulgaris (CACTUS): A Randomized, Controlled, Assessor-Blind, Phase III Clinical Trial.

Luan C, Yang WL, Yin JW, Deng LH, Chen B, Liu HW, Zhang SM, Han J, Liu ZJ, Dai XR, Yin QJ, Yu XH, Chen K, Gu H, Li BXY

Open source

DOI
10.1007/s13555-024-01286-x
Published
2024 Nov
Container
Dermatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-024-01286-x,
  title = {Efficacy and Safety of a Fixed-Dose Combination Gel with Adapalene 0.1\% and Clindamycin 1\% for the Treatment of Acne Vulgaris (CACTUS): A Randomized, Controlled, Assessor-Blind, Phase III Clinical Trial.},
  author = {Luan C and Yang WL and Yin JW and Deng LH and Chen B and Liu HW and Zhang SM and Han J and Liu ZJ and Dai XR and Yin QJ and Yu XH and Chen K and Gu H and Li BXY},
  year = {2024},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-024-01286-x},
  url = {https://doi.org/10.1007/s13555-024-01286-x}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of a Fixed-Dose Combination Gel with Adapalene 0.1% and Clindamycin 1% for the Treatment of Acne Vulgaris (CACTUS): A Randomized, Controlled, Assessor-Blind, Phase III Clinical Trial.
AU  - Luan C
AU  - Yang WL
AU  - Yin JW
AU  - Deng LH
AU  - Chen B
AU  - Liu HW
AU  - Zhang SM
AU  - Han J
AU  - Liu ZJ
AU  - Dai XR
AU  - Yin QJ
AU  - Yu XH
AU  - Chen K
AU  - Gu H
AU  - Li BXY
PY  - 2024
JO  - Dermatology and therapy
DO  - 10.1007/s13555-024-01286-x
UR  - https://doi.org/10.1007/s13555-024-01286-x
ER  - 

APA

C, L., WL, Y., JW, Y., LH, D., B, C., HW, L., SM, Z., J, H., ZJ, L., XR, D., QJ, Y., XH, Y., K, C., H, G., & BXY, L. (2024). Efficacy and Safety of a Fixed-Dose Combination Gel with Adapalene 0.1% and Clindamycin 1% for the Treatment of Acne Vulgaris (CACTUS): A Randomized, Controlled, Assessor-Blind, Phase III Clinical Trial.. Dermatology and therapy. https://doi.org/10.1007/s13555-024-01286-x

Source records